Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment
Clinical trial NCT01818596 · COMPLETED
Trial details
- NCT number
- NCT01818596
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-27
- Primary completion
- 2014-07-31
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.